| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/06/2002 | WO2002044321A2 Rna interference mediating small rna molecules |
| 06/06/2002 | WO2002044320A2 Human elongase genes and uses thereof |
| 06/06/2002 | WO2002044210A2 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | WO2002044209A2 Cytonkine receptor zcytor19 |
| 06/06/2002 | WO2002044207A1 Immunotherapeutic methods and molecules |
| 06/06/2002 | WO2002044183A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors |
| 06/06/2002 | WO2002044168A2 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | WO2002044165A1 Quinoline derivatives as nk-3 antagonists |
| 06/06/2002 | WO2002044158A1 Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents |
| 06/06/2002 | WO2002044154A1 Novel compounds |
| 06/06/2002 | WO2002044153A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 06/06/2002 | WO2002044141A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 06/06/2002 | WO2002044128A2 Salicylate analogs as interleukin-4 antagonists |
| 06/06/2002 | WO2002043785A2 Intraocular implants for preventing transplant rejection in the eye |
| 06/06/2002 | WO2002043774A2 Compositions and therapeutical use of polynucleotides encoding tcrs |
| 06/06/2002 | WO2002043758A2 Uses of mammalian genes and related reagents |
| 06/06/2002 | WO2002043756A2 Method for obtaining antigenic aggregates and the use thereof in formulations |
| 06/06/2002 | WO2002043755A1 Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes |
| 06/06/2002 | WO2002043745A2 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma |
| 06/06/2002 | WO2002043728A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/06/2002 | WO2002043649A2 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof |
| 06/06/2002 | WO2002043648A2 Compounds active at the glucocorticoid receptor ii |
| 06/06/2002 | WO2002026240A3 Inhibition of antigen presentation with poorly catabolized polymers |
| 06/06/2002 | WO2002022674A3 VARIANTS OF THE MAJOR ALLERGEN Par j 2 OF Parietaria judaica |
| 06/06/2002 | WO2002020489A3 QUINOLINE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 06/06/2002 | WO2002018320A3 INHIBITORS OF α4 MEDIATED CELL ADHESION |
| 06/06/2002 | WO2002014314A3 Substituted pyrazoles |
| 06/06/2002 | WO2002012242A3 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/06/2002 | WO2002011676A3 Method of using diketopiperazines and composition containing them |
| 06/06/2002 | WO2001090334A3 Drug metabolizing enzymes |
| 06/06/2002 | WO2001090129A3 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds |
| 06/06/2002 | WO2001090068A3 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases |
| 06/06/2002 | WO2001088116A9 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods |
| 06/06/2002 | WO2001087849A3 Modulators of tnf- alpha signaling |
| 06/06/2002 | WO2001079442A3 Albumin fusion proteins |
| 06/06/2002 | WO2001074128A3 A novel polypeptide, microtubulin 11 and the polynucleotide encoding the polypeptide |
| 06/06/2002 | WO2001072323A3 Use of insulin for the treatment of cartilagenous disorders |
| 06/06/2002 | WO2001068643A3 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 06/06/2002 | WO2001064907A3 Lipid metabolism enzymes |
| 06/06/2002 | WO2001064884A3 G12l, a gene associated with the thermal response |
| 06/06/2002 | WO2001036645A3 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same |
| 06/06/2002 | WO2000024782A3 Modified peptides, comprising an fc domain, as therapeutic agents |
| 06/06/2002 | US20020069422 Proteins for use in the treatment of trypanosome infection, cancer, inflammation and immunological defects |
| 06/06/2002 | US20020068830 Such as 1-((1-(3-(cyclopentyloxy)-4-methoxyphenyl) cyclopropyl)methyl)-1,3-dihydro-2H-imidazol-2-one for allergies, atopic and inflammatory diseases wherein activity of phosphodiesterase is altered |
| 06/06/2002 | US20020068756 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 06/06/2002 | US20020068746 Pyrrolo[2,3-d]pyrimidine compounds |
| 06/06/2002 | US20020068723 Altering the conformational equilibrium of the A- ring to favor a chair conformation that presents the 1 alpha-hydroxyl in the axial orientation. |
| 06/06/2002 | US20020068721 Purine derivatives |
| 06/06/2002 | US20020068714 Screening for agents that modulate tolerance to an immunogen; delivering a nucleic acid that directs expression of the immunogen to the liver of an animal, resulting in sustained expression of the immunogen in the liver. |
| 06/06/2002 | US20020068713 Genetic engineering of vascular grafts to resist disease |
| 06/06/2002 | US20020068704 Compositions and methods for treatment of diabetes |
| 06/06/2002 | US20020068696 Modulating proliferation and apoptotic state of cells using agents that modulate the expression and/or activity of TRADE family polypeptides. |
| 06/06/2002 | US20020068323 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics |
| 06/06/2002 | US20020068319 32 human secreted proteins |
| 06/06/2002 | US20020068303 Protein for us ein the treatment of immunological defects |
| 06/06/2002 | US20020068087 Bioadhesive hydrogels with functionalized degradable crosslinks |
| 06/06/2002 | US20020068083 Oil-free; bioavailability; useful as immunosuppressive agents, parasiticides, and agents for the reversal of multi-drug resistance |
| 06/06/2002 | US20020068062 Inhibitors of the formation of soluble human CD23 |
| 06/06/2002 | US20020068061 Antibody inhibits heparanase activity; prevent angiogenesis, cell proliferation, tumor cell proliferation, invasion of circulating tumor cells, metastases, inflammation and autoimmune conditions |
| 06/06/2002 | US20020068058 Autoantibody inhibitors |
| 06/06/2002 | US20020068045 Such as neural progenitor cells capable of giving rise to mature somatic cells including neural cells and/or glial cells recognizable by expression of specific markers |
| 06/06/2002 | EP1144454A3 Modified peptides as therapeutic agents |
| 06/06/2002 | DE10060388A1 Verwendung von Pyrazolo [4,3-d]pyrimidinen Use of pyrazolo [4,3-d] pyrimidines |
| 06/06/2002 | DE10051858A1 Verwendung von biologisch abbaubaren, substituierten Kohlenwasserstoffen deren Ester, Ether und/oder Amide als Nasensalbe oder Nasentropfen zur Prophylaxe von inhalationsallergischen Reaktionen und zur Pflege der Nasenschleimhaut Use of biologically degradable, substituted hydrocarbons their esters, ethers and / or amides as a nasal ointment or nasal drops for the prophylaxis of inhalation allergic reactions and for the care of the nasal mucosa |
| 06/06/2002 | CA2791831A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2457925A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/06/2002 | CA2436941A1 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | CA2436903A1 Immunotherapeutic methods and molecules |
| 06/06/2002 | CA2430526A1 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 06/06/2002 | CA2430485A1 Cytonkine receptor zcytor19 |
| 06/06/2002 | CA2430401A1 Uses of mammalian genes and related reagents |
| 06/06/2002 | CA2430354A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 06/06/2002 | CA2430341A1 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 06/06/2002 | CA2430311A1 Compounds active at the glucocorticoid receptor ii |
| 06/06/2002 | CA2430292A1 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof |
| 06/06/2002 | CA2430291A1 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma |
| 06/06/2002 | CA2430257A1 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | CA2430087A1 Photochemical internalization for delivery of molecules into the cytosol |
| 06/06/2002 | CA2429814A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2429749A1 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | CA2429599A1 Use of b7rp1 antagonists in ige-mediated disorders |
| 06/06/2002 | CA2429469A1 Human elongase genes and uses thereof |
| 06/06/2002 | CA2429382A1 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | CA2427996A1 Tolerizing allografts of pluripotent stem cells |
| 06/06/2002 | CA2422729A1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 06/05/2002 | EP1211311A2 Cord blood-derived activated lymphocytes and preparations containing said lymphocytes |
| 06/05/2002 | EP1211240A1 Biscyclopropanecarboxylic acid amide compounds and medicinal use thereof |
| 06/05/2002 | EP1210605A2 Analysis and treatment of body weight and eating disorders |
| 06/05/2002 | EP1210455A1 Novel glycosyl sulfotransferases gst-4 alpha, gst-4 beta, and gst-6 |
| 06/05/2002 | EP1210438A2 Ehrlichia canis genes and vaccines |
| 06/05/2002 | EP1210435A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 06/05/2002 | EP1210434A2 Mammalian interleukin-12 p40 and interleukin b30. combinations thereof. antibodies. uses in pharmaceutical compositions |
| 06/05/2002 | EP1210430A2 Muc-1 derived peptides |
| 06/05/2002 | EP1210429A2 Apoptosis proteins |
| 06/05/2002 | EP1210428A1 Pd-1, a receptor for b7-4, and uses therefor |
| 06/05/2002 | EP1210425A2 Baff receptor (bcma), an immunoregulatory agent |
| 06/05/2002 | EP1210424A1 Novel b7-4 molecules and uses therefor |
| 06/05/2002 | EP1210419A2 Human transmembrane proteins |
| 06/05/2002 | EP1210375A1 Recombinant proteins and molecular complexes derived therefrom, analogous to molecules involved in immune responses |
| 06/05/2002 | EP1210370A1 Human tumor necrosis factor receptor tr16 |